Johnson & Johnson Approaches Swiss Firm Actelion About Potential Deal

Swiss biopharmaceutical company Actelion said it had been approached by Johnson & Johnson about a possible deal.

from WSJ.com: US Business http://ift.tt/2fZYnC6
via IFTTT